Clinical Trial Update: A Study of KRN125 in Patients With Multiple Myeloma and Malignant Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for KRN125 in patients with multiple myeloma and malignant lymphoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Lymphoma
• Multiple Myeloma

Drugs mentioned

• KRN125 (KRN125)

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Multiple Myeloma and Malignant Lymphoma | Phase 2 | Status: COMPLETED